Voclosporin’s Efficacy Confirmed for All Lupus Nephritis Biopsy Classes
Add-on voclosporin improved complete renal response across all lupus nephritis biopsy classes, with the greatest benefit observed in pure class 3.
All articles by Natasha Persaud
COVID-19 Virus Spike Protein Detected in Urine
In a small study, 25% of adults with COVID-19 shed SARS-CoV-2 spike S1 protein in their urine at least once during the course of infection.
Study: Roxadustat Effectively Treats Anemia Across CKD Stages
Roxadustat reduced the need for rescue therapy among patients with any stage of chronic kidney disease.
Bisphosphonates May Treat Calciphylaxis in Kidney Transplant Recipients
Moderate to severe hyperparathyroidism after kidney transplantation may have predisposed 2 cases to calciphylaxis, according to investigators.
Low Potassium Dialysate May Improve Inpatient Survival
Modifying the potassium concentration used for dialysis may decrease mortality risk among hospitalized patients with end-stage kidney disease and severe hyperkalemia, according to investigators.
Albuminuria Reduction Greater With SGLT2 Inhibitor, ERA Combo
A move toward combination therapies is inevitable in the new paradigm for diabetic kidney disease management, according to the authors of an editorial.
Calcimimetic Found More Effective in Suppressing Calcification in HD
Trial findings suggest a calcimimetic may be more effective than a VDRA at reducing calcification in patients receiving hemodialysis.
Nicotinamide May Improve Phosphate Control in Hemodialysis Patients
Nicotinamide modulates expression of the sodium-dependent phosphate cotransporter 2b and thereby may inhibit intestinal phosphate absorption, according to investigators.
NSAID May Increase AKI Risk in Hospitalized Children
Avoiding inappropriate use and overdosing of drugs with nephrotoxic effects is an important strategy to prevent hospital-acquired AKI in children, according to investigators.
BPH Medications May Increase Heart Failure Risk
It is important for urologists and primary care physicians to be aware of the potential link between BPH medications and heart failure risk, according to investigators.
